鉴定通过皮肤冠状动脉干预后患者中导致动态恐惧症的因素
Lu Chen1, Jiang-Ying Li1, Zhen-Qing Ren2
1Department of cardiology, Taizhou School of Clinical Medicine, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Nanjing Medical University, Taizhou, 225300, China.
穿皮冠状动脉干预 (PCI) 后对运动的恐惧 (运动恐惧症) 源于压力,运动不确定性,低自我效能和缺乏支持. 解决这些因素是坚持心脏康复的关键.
科学领域:
- 心脏病学 心脏病学
- 心理学 心理学 心理学
- 康复医学 康复医学 康复医学
背景情况:
- 穿皮冠状动脉干预 (PCI) 是冠状动脉疾病的常见程序.
- 运动恐惧症,或对身体运动的恐惧,对于PCI后的患者来说,可能是一个重要的障碍.
- 了解导致动态恐惧症的因素对于改善患者的治疗结果至关重要.
研究的目的:
- 研究通过皮肤冠状动脉干预 (PCI) 后患者的运动恐惧症的多方面的因素.
- 确定心理,社会和自我效能相关的因素,这些因素加剧了这种患者群体对运动的恐惧.
主要方法:
- 半结构面试与PCI后的14名患者和4名医疗保健专业人员进行.
- 有目的的抽样确保了参与者符合特定的纳入和排除标准.
- 采用Colaizzi的七步方法对收集的定性数据进行了主题分析.
主要成果:
- 四个主要主题出现了:心理压力增加,对运动的不确定性增加,自我效能降低,支持系统不足.
- 这些因素共同导致PCI后患者的运动恐惧症的发展和持续.
- 这些发现突出了影响患者行为心理和社会决定因素的复杂相互作用.
结论:
- 运动恐惧症显著阻碍了对基本心脏康复方案的遵守.
- 早期识别和彻底分析导致动态恐惧症的因素至关重要.
- 根据这些因素制定有针对性的干预策略,可以提高康复的坚持,改善长期的心血管健康.
更多相关视频
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
06:39Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
Published on: August 18, 2016
相关概念视频
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Preparedness and Phobias
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Decreased pulse rate
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
